Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | EGLN2 | Q96KS0 | 4/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | STK10 | O94804 | 1/20 | 0.31 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17487146 | 1.00 | CA1 (0.39) | CA1CA2EGLN2CYP1A2ALDH1A1 | |
| SCHEMBL17490285 | 0.91 | CA1 (0.39) | CA1CA2CYP1A2ALDH1A1HSD17B10 | |
| SCHEMBL17490298 | 0.91 | CA1 (0.39) | CA1CA2CYP1A2ALDH1A1HSD17B10 | |
| SCHEMBL23349021 | 0.86 | CA1 (0.36) | CA1CA2EGLN2CYP1A2ALDH1A1 | |
| SCHEMBL25642001 | 0.83 | CYP1A2 (0.36) | CA1CA2EGLN2CYP1A2ALDH1A1 | |
| SCHEMBL17487135 | 0.81 | CA1 (0.40) | CA1CA2CYP1A2ALDH1A1HSD17B10 | |
| SCHEMBL17487130 | 0.81 | CA1 (0.40) | CA1CA2CYP1A2ALDH1A1HSD17B10 | |
| SCHEMBL22824243 | 0.81 | ALDH1A1 (0.34) | CA1CA2CYP1A2ALDH1A1HSD17B10 | |
| SCHEMBL17490269 | 0.80 | CYP1A2 (0.41) | CA1CA2CYP1A2ALDH1A1HSD17B10 | |
| SCHEMBL17490270 | 0.80 | CYP1A2 (0.41) | CA1CA2CYP1A2ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9472766-B2 | Fused polycyclic compound and organic light emitting element including the same | CANON KABUSHIKI KAISHA (JP) | 2016-10-18 | — | — | US | disclosed |
| US-9472766-B2 | Fused polycyclic compound and organic light emitting element including the same | CANON KABUSHIKI KAISHA (JP) | 2016-10-18 | — | — | US | disclosed |
| US-20160035982-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2016-02-04 | — | — | US | disclosed |
| US-20160035982-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2016-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160035982-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME | NR2E3, PUF60, CRY2 | CA1 2115/4885CA2 2411/4885EGLN2 2453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.